News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
115,293 Results
Type
Article (6078)
Company Profile (5)
Press Release (109229)
Multimedia
Podcasts (21)
Webinars (5)
Section
Business (49147)
Career Advice (381)
Deals (8831)
Drug Delivery (24)
Drug Development (9195)
Employer Resources (30)
FDA (1632)
Job Trends (1990)
News (61061)
Policy (4354)
Tag
2027 Pharm Country Standard (1)
Academia (302)
Accelerated approval (13)
ADA (5)
Adcomms (3)
Allergies (24)
Alliances (5846)
ALS (31)
Alzheimer's disease (225)
Antibody-drug conjugate (ADC) (109)
Approvals (1683)
Artificial intelligence (119)
ASCO (38)
Autoimmune disease (69)
Automation (12)
Bankruptcy (121)
Belgium (1)
Best Places to Work (1641)
BIO (9)
Biologics (1)
BIOSECURE Act (2)
Biosimilars (60)
BioSpace Insights (19)
Biotechnology (11)
Bladder cancer (13)
Brain cancer (9)
Breast cancer (103)
Cancer (823)
Cardiovascular disease (59)
Career advice (348)
Career pathing (9)
CAR-T (54)
CDC (11)
CDMO (23)
Celiac Disease (2)
Cell therapy (154)
Cervical cancer (9)
Clinical research (8173)
Collaboration (351)
Commercialization (2)
Company closure (3)
Compensation (104)
Complete response letters (14)
COVID-19 (392)
CRISPR (15)
C-suite (642)
Cystic fibrosis (30)
Data (1129)
Denatured (5)
Depression (41)
Dermatology (8)
Diabetes (102)
Diagnostics (1013)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (65)
Drug pricing (26)
Drug shortages (5)
Duchenne muscular dystrophy (97)
Earnings (20154)
Editorial (22)
Employer branding (1)
Employer resources (29)
Events (12708)
Executive appointments (547)
FDA (2275)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (393)
Gene editing (36)
Generative AI (9)
Gene therapy (140)
GLP-1 (169)
Government (640)
Grass and pollen (1)
Guidances (93)
Healthcare (3363)
Hematology (24)
HIV (9)
Huntington's disease (10)
IgA nephropathy (20)
Immunology and inflammation (51)
Immuno-oncology (27)
Indications (32)
Infectious disease (458)
Inflammatory bowel disease (47)
Inflation Reduction Act (2)
Influenza (25)
Intellectual property (87)
Interviews (47)
IPO (3869)
IRA (8)
Job creations (366)
Job search strategy (294)
JPM (4)
Kidney cancer (8)
Labor market (16)
Layoffs (75)
Leadership (15)
Legal (1151)
Licensing (6)
Liver cancer (12)
Longevity (7)
Lung cancer (120)
Lymphoma (41)
Machine learning (13)
Management (7)
Manufacturing (190)
Marketing (3)
MASH (49)
Medical device (2549)
Medtech (2606)
Mergers & acquisitions (5485)
Metabolic disorders (253)
mRNA (25)
Multiple sclerosis (39)
NASH (3)
Netherlands (1)
Neurodegenerative disease (68)
Neuropsychiatric disorders (24)
Neuroscience (535)
NextGen: Class of 2026 (1024)
Non-profit (458)
Now hiring (5)
Obesity (101)
Opinion (88)
Ovarian cancer (34)
Pain (51)
Pancreatic cancer (32)
Parkinson's disease (59)
Partnered (3)
Patents (162)
Patient recruitment (129)
Peanut (6)
People (18162)
Pharmaceutical (6)
Pharmacy benefit managers (6)
Phase 1 (2573)
Phase 2 (3838)
Phase 3 (2786)
Pipeline (2141)
Policy (62)
Postmarket research (168)
Preclinical (928)
Press Release (17)
Prostate cancer (34)
Psychedelics (19)
Radiopharmaceuticals (88)
Rare diseases (215)
Real estate (576)
Recruiting (17)
Regulatory (3609)
Reports (24)
Research institute (319)
Resumes & cover letters (46)
Rett syndrome (3)
RNA editing (1)
RSV (8)
Schizophrenia (59)
Series A (85)
Series B (47)
Service/supplier (1)
Sickle cell disease (17)
Special edition (5)
Spinal muscular atrophy (20)
Sponsored (13)
Startups (587)
State (1)
Stomach cancer (1)
Supply chain (23)
Tariffs (7)
The Weekly (16)
Vaccines (170)
Venture capital (32)
Weight loss (61)
Women's health (19)
Worklife (2)
Date
Today (36)
Last 7 days (112)
Last 30 days (467)
Last 365 days (5747)
2026 (4131)
2025 (5479)
2024 (6665)
2023 (7243)
2022 (9840)
2021 (10149)
2020 (9242)
2019 (7164)
2018 (5560)
2017 (5419)
2016 (4918)
2015 (5684)
2014 (4232)
2013 (3255)
2012 (3487)
2011 (3621)
2010 (3330)
Location
Africa (122)
Alabama (26)
Alaska (2)
Arizona (69)
Arkansas (5)
Asia (7854)
Australia (1109)
California (2441)
Canada (983)
China (353)
Colorado (132)
Connecticut (123)
Delaware (111)
Europe (16907)
Florida (506)
Georgia (99)
Idaho (7)
Illinois (216)
India (18)
Indiana (136)
Iowa (3)
Japan (147)
Kansas (14)
Kentucky (7)
Louisiana (4)
Maine (9)
Maryland (349)
Massachusetts (1695)
Michigan (44)
Minnesota (117)
Missouri (16)
Montana (13)
Nebraska (7)
Nevada (26)
New Hampshire (22)
New Jersey (923)
New Mexico (8)
New York (676)
North Carolina (408)
Northern California (1243)
Ohio (74)
Oklahoma (4)
Oregon (3)
Pennsylvania (491)
Puerto Rico (13)
Rhode Island (9)
South America (191)
South Carolina (6)
Southern California (1001)
Tennessee (33)
Texas (446)
United States (9205)
Utah (56)
Vermont (1)
Virginia (41)
Washington D.C. (23)
Washington State (165)
West Virginia (1)
Wisconsin (24)
Wyoming (2)
115,293 Results for "griggs holdings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five patients enrolled in REGENXBIO’s registrational trial. The biotech no longer plans to resubmit the candidate—which was rejected in February—in the near term.
August 24, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - September 7, 2026
September 7, 2026
·
3 min read
Press Releases
Zealand Pharma – Notification of holding of treasury shares
August 24, 2026
·
1 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
August 7, 2026
·
11 min read
Press Releases
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
August 6, 2026
·
21 min read
Press Releases
Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis
August 31, 2026
·
3 min read
Press Releases
Medpace Holdings, Inc. Reports Second Quarter 2026 Results
July 23, 2026
·
18 min read
Lung cancer
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
The data, which come from a subgroup in an earlier trial that Truist Securities called “the most relevant” to Revolution Medicines’ ongoing Phase 3 test in RAS mutant NSCLC, showed a 42% overall response rate and overall survival of 16 months.
September 3, 2026
·
2 min read
·
Heather McKenzie
Press Releases
QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting
July 29, 2026
·
1 min read
1 of 11,530
Next
